---
pmid: '29225034'
title: Cytosolic Iron-Sulfur Assembly Is Evolutionarily Tuned by a Cancer-Amplified
  Ubiquitin Ligase.
authors:
- Weon JL
- Yang SW
- Potts PR
journal: Mol Cell
year: '2018'
full_text_available: false
doi: 10.1016/j.molcel.2017.11.010
---

# Cytosolic Iron-Sulfur Assembly Is Evolutionarily Tuned by a Cancer-Amplified Ubiquitin Ligase.
**Authors:** Weon JL, Yang SW, Potts PR
**Journal:** Mol Cell (2018)
**DOI:** [10.1016/j.molcel.2017.11.010](https://doi.org/10.1016/j.molcel.2017.11.010)

## Abstract

1. Mol Cell. 2018 Jan 4;69(1):113-125.e6. doi: 10.1016/j.molcel.2017.11.010. Epub
 2017 Dec 7.

Cytosolic Iron-Sulfur Assembly Is Evolutionarily Tuned by a Cancer-Amplified 
Ubiquitin Ligase.

Weon JL(1), Yang SW(1), Potts PR(2).

Author information:
(1)Department of Cell and Molecular Biology, St. Jude Children's Research 
Hospital, 262 Danny Thomas Place, Memphis, TN 38105-3678, USA.
(2)Department of Cell and Molecular Biology, St. Jude Children's Research 
Hospital, 262 Danny Thomas Place, Memphis, TN 38105-3678, USA. Electronic 
address: ryan.potts@stjude.org.

Comment in
    Nat Chem Biol. 2018 Feb 14;14(3):199. doi: 10.1038/nchembio.2580.

The cytosolic iron-sulfur (Fe-S) cluster assembly (CIA) pathway functions to 
incorporate inorganic Fe-S cofactors into a variety of proteins, including 
several DNA repair enzymes. However, the mechanisms regulating the CIA pathway 
are unknown. We describe here that the MAGE-F1-NSE1 E3 ubiquitin ligase 
regulates the CIA pathway through ubiquitination and degradation of the 
CIA-targeting protein MMS19. Overexpression or knockout of MAGE-F1 altered Fe-S 
incorporation into MMS19-dependent DNA repair enzymes, DNA repair capacity, 
sensitivity to DNA-damaging agents, and iron homeostasis. Intriguingly, MAGE-F1 
has undergone adaptive pseudogenization in select mammalian lineages. In 
contrast, MAGE-F1 is highly amplified in multiple human cancer types and 
amplified tumors have increased mutational burden. Thus, flux through the CIA 
pathway can be regulated by degradation of the substrate-specifying MMS19 
protein and its downregulation is a common feature in cancer and is 
evolutionarily controlled.

Copyright Â© 2017 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.molcel.2017.11.010
PMID: 29225034 [Indexed for MEDLINE]
